Cytori Therapeutics, Inc. Completes Collaboration With Olympus Corporation; Receives Initial $11.0 Million Payment From Olympus-Cytori Joint Venture

SAN DIEGO--(BUSINESS WIRE)--Dec. 9, 2005--Cytori Therapeutics, Inc. (Frankfurt:XMPA) announced today it has formally completed its formation of the recently announced regenerative medicine collaboration it entered into with Olympus Corporation. As part of the closing, the two companies have incorporated the 50:50 Joint Venture, Olympus-Cytori, Inc., to develop and manufacture future generation devices based on Cytori’s Celution(TM) System. Additionally, Cytori has received the $11.0 million initial payment from the Joint Venture as Cytori has granted an exclusive license to its therapeutic device technology, including the Celution(TM) System, and certain related intellectual property, to the Joint Venture.

MORE ON THIS TOPIC